Inhibitors of human immunodeficiency virus replication

US8906929B2 · kind B2 · utility

Assignee

• Bristol-Myers Squibb Company · US

Inventors

• B. Narasimhulu Naidu · Durham, US
• Manoj Patel · Berlin, US
• Stanley D'Andrea · Middletown, US
• Zhizhen Barbara Zheng · Cheshire, US
• Timothy P. Connolly · Portland, US
• David R. Langley · Meriden, US
• Kevin Peese · Haddam, US
• Zhongyu Wang · Nanjing, CN
• Michael A. Walker · Durham, US
• John F. Kadow · Wallingford, US

Key dates

• Filing date: Aug 5, 2013
• Grant date: Dec 9, 2014
• Expiry date: Aug 5, 2033

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D498/22
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The disclosure generally relates to compounds of formula I, including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of HIV infection.